Shetzline Michael
SEC CIK 1808509 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IRWD | IRONWOOD PHARMACEUTICALS INC | SVP, CMO, Head-Res, Drug | 658.0K | — | $1.55M | 19 | 2021-11-23 | 2026-03-10 |
Most active insiders at IRWD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DENNER ALEXANDER J | Dir, 10% | — | $20.53M |
| 2 | Silver Ronald | Principal Accounting Off | — | $831.2K |
| 3 | MCCOURT Thomas A | CEO, Dir | — | $739.9K |
| 4 | John Minardo | CLO | — | $136.2K |
| 5 | Gaskins Tammi L | Chief Commercial Off | — | $100.3K |
| 6 | Martini Gregory S. | CFO | — | $81.9K |
| 7 | McHugh Julie | Dir | — | $80.5K |
| 8 | Silber Jeffrey | SVP, CMO, Head-Res, Drug | — | — |
| 9 | Moukheibir Catherine | Dir | — | — |
| 10 | Duane Jon R | Dir | — | — |
| 14 | Shetzline Michael | SVP, CMO, Head-Res, Drug | — | -$5,381 |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-12 | 2026-03-10 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | SVP, CMO, Head-Res, Drug | A - Grant | $0.00 | +136.6K | 658.0K | +26% | $0 | |
| M | 2026-02-25 | 2026-02-23+ | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | SVP, CMO, Head-Res, Drug | S - Sale | $3.73 | +1,442 | 521.4K | +0.3% | +$5,381 |
| 2025-02-12 | 2025-02-10 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | SVP, CMO, Head-Res, Drug | A - Grant | $0.00 | +133.3K | 595.3K | +29% | $0 | |
| 2025-02-12 | 2025-02-10 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | SVP, CMO, Head-Res, Drug | S - Sale | $1.76 | -41.3K | 554.0K | -7% | -$72.6K | |
| 2025-01-22 | 2025-01-17 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | SVP, CMO, Head-Res, Drug | A - Grant | $0.00 | +48.2K | 461.9K | +12% | $0 | |
| 2024-05-22 | 2024-05-20 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | CMO, SVP, Head-Res, Drug | S - Sale | $6.45 | -16.1K | 413.7K | -4% | -$104.0K | |
| D | 2024-03-12 | 2024-03-08 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | CMO, SVP, Head-Res, Drug | M - OptEx | $0.00 | +34.9K | 429.8K | +9% | $0 |
| D | 2024-02-14 | 2024-02-12 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | CMO, SVP, Head-Res, Drug | S - Sale | $15.24 | -38.6K | 340.5K | -10% | -$588.5K |
| D | 2024-02-14 | 2024-02-12 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | CMO, SVP, Head-Res, Drug | A - Grant | $0.00 | +54.4K | 394.9K | +16% | $0 |
| 2024-01-19 | 2024-01-17 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | CMO, SVP, Head-Res, Drug | A - Grant | $0.00 | +58.0K | 379.1K | +18% | $0 | |
| 2023-05-24 | 2023-05-22 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | CMO, SVP, Head-Res, Drug | S - Sale | $10.12 | -10.3K | 321.1K | -3% | -$104.5K | |
| D | 2023-03-10 | 2023-03-08 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | CMO, SVP, Head-Res, Drug | A - Grant | $0.00 | +69.9K | 331.5K | +27% | $0 |
| M | 2023-03-01 | 2023-02-27+ | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | CMO, SVP, Head-Res, Drug | S - Sale | $11.36 | -19.3K | 271.4K | -7% | -$219.5K |
| 2023-01-19 | 2023-01-17 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | CMO, SVP, Head-Res, Drug | A - Grant | $0.00 | +14.7K | 280.9K | +6% | $0 | |
| M | 2022-05-25 | 2022-05-23 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | CMO, SVP, Head-Res, Drug | S - Sale | $11.50 | -10.6K | 266.2K | -4% | -$121.7K |
| 2022-03-04 | 2022-03-02 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | CMO, SVP, Head-Res, Drug | A - Grant | $0.00 | +81.4K | 276.8K | +42% | $0 | |
| M | 2022-03-02 | 2022-02-28 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | CMO, SVP, Head-Res, Drug | S - Sale | $10.77 | -17.6K | 211.6K | -8% | -$189.6K |
| 2022-01-21 | 2022-01-19 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | CMO, SVP, Head-Res, Drug | A - Grant | $0.00 | +29.3K | 213.0K | +16% | $0 | |
| 2021-11-24 | 2021-11-23 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | CMO, SVP, Head-Res, Drug | S - Sale | $11.58 | -13.8K | 183.7K | -7% | -$159.5K |
Purchase Sale Sale after option exercise All abbreviations